EMG
BLRX

ETF Managers Group’s BioLineRX BLRX Stock Holding History

ETF Managers Group’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,194
Closed -$123K – 533
2019
Q3 		$123K Buy
+1,194
New +$166K ﹤0.01% 518
2019
Q2 		– Sell
-607
Closed -$157K – 580
2019
Q1 		$157K Sell
607
-20
-3% -$5.82K 0.01% 379
2018
Q4 		$164K Buy
627
+278
+80% +$134K 0.01% 311
2018
Q3 		$224K Buy
+349
New +$192K 0.01% 241
2018
Q2 		– Sell
-209
Closed -$106K – 498
2018
Q1 		$106K Buy
209
+34
+19% +$20.8K 0.01% 264
2017
Q4 		$115K Buy
175
+16
+10% +$10.5K 0.01% 228
2017
Q3 		$107K Buy
159
+9
+6% +$5.59K 0.01% 139
2017
Q2 		$76K Buy
+150
New +$77.1K 0.01% 204

Other funds holding BLRX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
CCB
Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return
NFG
Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return
RE
RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return

ETF Managers Group's BLRX Position: Q4 2019 in Review

ETF Managers Group sold out of BioLineRX (BLRX) in Q4 2019, closing a stake of 1,194 shares — an estimated $123K sold.

ETF Managers Group first reported a position in BLRX in Q2 2017 and held it in 8 quarters. The position peaked at $224K in Q3 2018. 12 funds tracked by Wall St. Rank hold BLRX as of Q4 2019.

  • ETF Managers Group reported no remaining BioLineRX position as of Q4 2019 after selling out during the quarter.
  • ETF Managers Group sold 1,194 BioLineRX shares in Q4 2019, an estimated $123K.
  • ETF Managers Group first reported a position in BioLineRX in Q2 2017 and held it in 8 quarters.
  • ETF Managers Group's BioLineRX position peaked at $224K in Q3 2018.
  • 12 funds tracked by Wall St. Rank held BioLineRX as of Q4 2019.

Based on ETF Managers Group's 13F filing for Q4 2019, filed 14 Feb 2020.